ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.020
-0.030 (-2.86%)
Sep 29, 2026, 1:59 PM EDT - Market open
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $26.44 million as of September 29, 2026. Its market cap has decreased by -64.46% in one year.
Market Cap
26.44M
Enterprise Value
29.24M
1-Year Change
-64.46%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $26.44M, a decrease of -66.74%. That is a compound annual growth rate of -19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 28.00M | -45.95% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 29.98M |
| CEL-SCI | 29.90M |
| Quince Therapeutics | 29.49M |
| aTyr Pharma | 29.20M |
| TransCode Therapeutics | 28.95M |
| IGC Pharma | 28.33M |
| Kyntra Bio | 27.94M |
| LeonaBio | 27.04M |